Abstract Aims/hypothesis: Obese people exhibit reduced circulating peptide YY (PYY) levels, but it is unclear whether this is a consequence or cause of obesity. We therefore investigated the effect of Pyy ablation on energy homeostasis. Methods: Body composition, i.p. glucose tolerance, food intake and hypothalamic neuropeptide expression were determined in Pyy knock-out and wildtype mice on a normal or high-fat diet. Results: Pyy knock-out significantly increased bodyweight and increased fat mass by 50% in aged females on a normal diet. Male chow-fed Pyy −/− mice were resistant to obesity but became significantly fatter and glucose-intolerant compared with wild-types when fed a high-fat diet. Pyy knock-out animals exhibited significantly elevated fasting or glucose-stimulated serum insulin concentrations vs wild-types, with no increase in basal or fasting-induced food intake. Pyy knock-out decreased or had no effect on neuropeptide Y expression in the arcuate nucleus of the hypothalamus, and significantly increased proopiomelanocortin expression in this region. Male but not female knock-outs exhibited significantly increased growth hormone-releasing hormone expression in the ventromedial hypothalamus and significantly elevated serum IGF-I and testosterone levels. This sex difference in activation of the hypothalamo-pituitary somatotrophic axis by Pyy ablation may contribute to the resistance of chow-fed male knockouts to late-onset obesity. Conclusions/interpretation: PYY signalling is important in the regulation of energy balance and glucose homeostasis, possibly via regulation of insulin release. Therefore reduced PYY levels may predispose to the development of obesity, particularly with ageing or under conditions of high-fat feeding.
Introduction
The gut hormone peptide YY (PYY) belongs to the neuropeptide Y (NPY) family along with pancreatic polypeptide (PPY) [1] . PYY, PPY and NPY mediate their effects through Y receptors, of which there are several types (Y1, Y2, Y4, Y5 and Y6) [2] . The endocrine L cells of the lower gastrointestinal tract are the major source of PYY; however, PYY is also produced in the alpha cells of the islets of Langerhans as well as in the stomach and the brainstem [3] .
There are two endogenous forms of PYY: PYY1-36 and PYY3-36. The latter is produced by the action of the cellsurface enzyme dipeptidyl peptidase IV on secreted PYY1-36 [4] . PYY1-36 binds to all known Y receptors, albeit with differing affinities, whereas PYY3-36 is more selective for the Y2 receptor and to a lesser extent to the Y5 receptor [5] . Upon ingestion of a meal, PYY levels rise within 15 min, peak at 60 min and remain elevated for up to 6 h in humans [6] . The initial rise of PYY appears to be due to an indirect neural reflex, whereas the sustained release of PYY appears to be a direct effect of intraluminal contents on endocrine L cells [7] . Dietary fat is the most potent stimulant of PYY release [6] .
Both PYY1-36 [8, 9] and PYY3-36 suppress appetite and food intake in rodents [10] [11] [12] [13] [14] . However, one report was unable to confirm this finding [15] . Most studies investigating the role of PYY in energy balance have focused primarily on its effects on feeding and bodyweight, and less is known about the role of PYY in influencing body composition and hormonal and metabolic parameters that influence it, such as leptin etc. Indeed, many factors that play a significant role in regulating energy homeostasis do so in the absence of corresponding effects on food intake or bodyweight [16, 17] . There is evidence that PYY could influence energy balance via multiple pathways aside from effects on food intake. Notably, PYY has been shown to slow the transit of food through the gastrointestinal tract, delay gastric and gallbladder emptying [6, 18] and delay pancreatic and intestinal secretion [19] via direct actions on target tissues or indirect actions via vagal pathways [7] .
It has also been implied that PYY has an important function in regulating insulin release and glucose homeostasis. Previous in vitro studies demonstrate that PYY acts to inhibit insulin secretion and glucose-stimulated insulin release from isolated pancreatic islets [20, 21] . In obese rodent models PYY3-36 reinforces insulin action on glucose disposal independently of changes in food intake and bodyweight [14, 22] . Since changes in gastrointestinal function and circulating insulin concentrations per se have been shown to have profound effects on energy balance [23] [24] [25] , it is possible that PYY may influence long-term energy balance via these mechanisms.
The aim of this work was to elucidate the role of PYY in the regulation of multiple hormonal and metabolic determinants of lean and fat mass. To this end, we generated Pyy knock-out mice and studied them under a range of conditions that are known to influence energy homeostasis, notably fasting, ageing and a high-fat diet.
Material and methods

Animal care
All research and animal care procedures were approved by the Garvan Institute/St Vincent's Hospital Animal Experimentation Ethics Committee.
Pyy targeting vector construction and gene disruption
The 130 kb mouse genomic BAC clone was mapped and various fragments were subcloned. A 10.5 kb SpeI fragment containing 6 kb 5′-flanking sequence, the entire Pyy gene and a 3 kb 3′-flanking sequence was chosen for the construction of a Pyy-Cre knock-in construct. The linearised version of that clone was transfected into ES cells. Two positive clones were injected into C57BL/6 blastocysts and chimeric mice were bred to generate heterozygous mice, and subsequently homozygous Pyy-Cre knock-in mice were bred. The genotype of the mice were determined by Southern blot analysis of NheI-digested DNA employing probes located outside the targeting sequence. Probe A and B were generated by PCR (A for: 5′-AGTGATTTGCTCA GAAGC-3′ and rev: 5′-CTAGTTCTATAGACCAGAC-3′) and (B for: 5′-CTGCCATGGCTGACCATGC-3′ and B rev: 5′-TGGT GGTGGCATGCACAC-3′). The conditions for all PCR reactions were 35 cycles of 94°C for 45 s, 58°C for 1 min and 72°C for 20 s.
Measurement of food intake and bodyweight
Wild-type and Pyy −/− animals originating from three or four different breeding pairs were housed under conditions of controlled temperature (22°C) and lighting (12-h light cycle, lights on at 07.00 h). Male and female wild-type and Pyy −/− mice had free access to a normal chow diet (6% of calories from fat, 21% from protein, 71% from carbohydrate; 2.6 kcal/g; Gordon's Speciality Stock Feeds, Yanderra, NSW, Australia). Separate groups of wild-type and Pyy −/− mice were fed a high-fat diet (46% of calories from fat, 21% from protein, 33% from carbohydrate; 4.72 kcal/g) from 4 to 5 weeks of age onwards. The high-fat diet, made in-house, was based on the composition of Rodent Diet Catalogue Number D12451 (Research Diets, New Brunswick, NJ, USA), with the exception that safflower oil and copha were used in place of soybean oil and lard, respectively. Bodyweight was monitored weekly from 4 to 28 weeks of age for the chow-fed animals and 4 to 14 weeks of age for the highfat-fed animals. At 11 to 12 weeks of age, basal and fasting-induced food and water intake were measured. Basal food and water intake were also determined at 24 weeks of age in male and female Pyy −/− and control mice.
Glucose tolerance tests At 13 weeks of age, chow-fed and high-fat-fed wild-type and Pyy knock-out mice were fasted for 24 h prior to i.p. glucose tolerance tests (1 g/kg). Serial blood samples were collected from the tail for determination of serum glucose and insulin levels. Glucose AUCs were calculated between 0 and 120 min after glucose injection and expressed as mmol·l
. Insulin AUCs were calculated between 0 and 120 min after glucose injection and expressed as pmol·l
Tissue collection and analysis
Wild-type and Pyy −/− mice at 14 or 28 weeks of age were killed by cervical dislocation between 12.00 and 14.00 h for collection of trunk blood. Brains were immediately removed and frozen on dry ice. Mice were scanned for whole-body lean and fat mass using a dual-energy X-ray absorptiometry (DXA) (Lunar PIXImus2 mouse densitometer; GE Healthcare Technologies, Waukesha, WI, USA). White adipose tissue depots (right inguinal, right epididymal or periovarian [gonadal] , right retroperitoneal and mesenteric) were removed and weighed. Serum glucagon levels were measured by RIA kits from Linco Research (St Louis, MO, USA), insulin levels were measured using an ELISA kit from Mercodia (Uppsala, Sweden), serum-free T4 and testosterone concentrations were measured with kits from ICN Biomedicals (Costa Mesa, CA, USA), serum IGF-I was determined using an RIA kit from Bioclone (Marrickville, NSW, Australia), serum glucose was determined with a glucose oxidase assay kit (Trace Scientific, Melbourne, VIC, Australia), and serum triglyceride and NEFAs were determined with kits from Roche Diagnostics (Mannheim, Germany) and Wako (Osaka, Japan), respectively.
PYY, glucagon and PPY staining
Pancreas and segments of the small intestine and colon obtained from three wild-type and three knock-out animals were fixed in 4% paraformaldehyde in PBS, processed, embedded in paraffin and cut at 7 μm sections. Sections were deparaffinised, rehydrated and incubated in 1% H 2 O 2 in methanol for 20 min. Sections were then rinsed in PBS and blocked with either 20% normal goat serum or donkey serum in PBS for 20 min. Rabbit anti-human PYY antiserum (1:1,000) (Peninsula Laboratories, CA, USA), rabbit anti-glucagon antibody (1:500) (ICN), or guinea pig anti-rat PPY serum (Linco Research) (1:1,000) was applied for 1 h at room temperature. For the PYY antibody, crossreactivity was minimised by incubating the antiserum with protein extracted from brain of Pyy −/− mice. Slides were rinsed in PBS before incubation with a peroxidaseconjugated goat anti-rabbit IgG (H+L) antibody (1:1,000) (Zymed Laboratories, San Francisco, CA, USA) or a biotinylated donkey anti-guinea-pig IgG antibody (1:5,000) (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) for 30 min at room temperature. The sections incubated with the biotinylated antibody were rinsed in PBS and incubated with Avidin-Biotin-Peroxidase Vectastain (Vector Laboratories, Burlingame, CA, USA) for 30 min at room temperature. Sections were washed in PBS and treated with diaminobenzidine from DAKO (Carpinteria, CA, USA) for 5 min. Slides were rinsed in water, counterstained with haematoxylin and dehydrated through to xylene before coverslipping.
Measurement of islet cell size and number
Six random pancreatic sections were collected from five wild-type and five Pyy −/− male mice. H&E stained sections were observed using a ProgRes 3008 camera (Zeiss, Jena, Germany) mounted on a Zeiss Axiophot microscope. The average number and size of islet cells per section were quantified using the ×20 objective and Leica IM 1000 version 1.20 software (Leica Microsystems, Heerbrig, Switzerland).
In situ hybridisation
Coronal brain sections (20 μm) were cut on a cryostat and thaw-mounted on Superfrost slides (Menzel-Glaser, Brunswick, Germany). Matching sections from the same coronal brain level of Pyy knock-out and wild-type mice (n=5 mice/ group) were assayed together using DNA oligonucleotides complementary to mouse Npy (5′-GAGGGTCAGTCCA CACAGCCCCATTCGCTTGTTACCTAGCAT-3′); mouse proopiomelanocortin (Pomc) (5′-TGGCTGCTCTCCAGG CACCAGCTCCACACATCTATGGAGG-3′); and mouse growth hormone-releasing hormone (Ghrh) (5′-GCTTGT CCTCTGTCCACATGCTGTCTTCCTGGCGGCTYGAG CCTGG-3′) as described previously [26] .
For evaluation of mRNA levels in scattered neurons, images from dipped sections were digitised using a ProgRes 3008 camera (Zeiss) mounted on a Zeiss Axiophot microscope. Silver grain density over single neurons was evaluated using NIH-Image 1.61 software (written by Wayne Rasband and available from anonymous FTP at zippy.nimh.nih.gov). Background labelling was uniform and never exceeded 5% of specific signal.
Activity measurements
The total cage activity was recorded using a passive infrared detector (PID) (Conrad Electronics, Hirschau, Germany) on top of the cage lid of single-housed 16-weekold chow-fed animals. The signals of the PIDs were detected by an I/O interface card (PIO48 II; Dr Schetter BMC Ing, Puchheim, Germany) and stored using custommade software. To show the activity pattern of the mice, data were plotted so that each cycle's activity is shown both to the right and below that of the previous cycle, a so-called double-plotted actogram with the x-axis showing 48 h starting on the left with 00.00 h (ZT 6). In order to test for differences in total activity between the genotypes, the activity counts were summed up to 30-min bins and a mean/day was calculated by averaging corresponding bins of seven consecutive days.
Statistical analyses
Results for bodyweight, lean and fat mass, food intake, activity measurements and differences in serum glucose and insulin levels during glucose tolerance tests were compared among groups using repeated-measures ANOVA followed by Fisher's post hoc tests. Differences in serum hormone and metabolite concentrations between Pyy −/− and wild-type mice were assessed by ANOVA with subsequent Fisher's post hoc tests. Alterations in neuro-peptide mRNA expression and pancreatic islet parameters between knock-out and wild-type mice were assessed by ANOVA. StatView version 4.5 (Abacus Concepts, Berkeley, CA, USA) was used for all statistical analyses and p<0.05 was accepted as being statistically significant.
Results
Generation of Pyy knock-out mice
A knock-out-targeting vector for the Pyy gene was designed which also allows the Pyy promoter-driven expression of the Cre-recombinase gene under control of the inducible tetracycline promoter (Fig. 1a) . Two positive ES cell clones for the Pyy construct were used to obtain chimeric mice, heterozygotes, and subsequently homozygous knock-out mice. DNA isolated from tail tips was used in Southern blot analysis (NheI) to confirm correct integration and modification of the targeted allele (Fig. 1b,c) .
Breeding of heterozygous germline knock-out animals produced a slight deviation from the expected Mendelian ratio of genotypes of 25:50:25 to 43:38:19 (wild-types: heterozygotes:homozygous knock-outs, n=7 breeding pairs). However, Pyy −/− mice breed normally with an average litter size of 7.15±0.37 pups/litter, which was not significantly different from wild-type litter sizes of 6.57± 0.97 pups (n=7-13 breeding pairs). The gender ratio in Pyy −/− offspring shows a trend towards a greater proportion of females (57.1%, n=112).
Unaltered tissue morphology in Pyy
−/− mice Successful deletion of the Pyy gene was confirmed by the absence of staining for PYY in the pancreas and colon of Pyy −/− mice ( Fig. 2a-d) . The morphology of these PYYexpressing tissues did not show any obvious changes when examined using H&E staining. Moreover, the average size of the islets of Langerhans in knock-out mice (0.013± 0.0002 mm 2 ) did not differ significantly from that of wildtype mice (0.020±0.0005 mm 2 ) (n=5 mice/genotype). The same is true for the number of islets per section (8.2±1.5 in wild-type mice vs 6.6±1.3 in Pyy −/− mice, six sections from five mice of each genotype). Importantly, the expression of the Ppy gene, which is located only 7 kb downstream of the Pyy gene locus, was not influenced by the removal of the Pyy gene (Fig. 2e,f) , nor was the expression of glucagon (Fig. 2g,h ) or insulin (data not shown) in the islets of Langerhans.
Effects of Pyy deletion on bodyweight, adiposity and food intake No change in bodyweight was observed in male Pyy −/− mice between 4 and 28 weeks of age under chow-fed conditions (Fig. 3a,b) , which was also confirmed by the comparison of body-weight AUC measurements (wildtype 628.5±7.8 g/24 weeks vs Pyy −/− 657.1±21.3 g/24 weeks) (p=0.2). However, female Pyy −/− mice had a significantly higher bodyweight than controls under chowfed conditions from 4 to 28 weeks of age (Fig. 3a) (AUC: wild-type 505.0±8.9 g/24 weeks; Pyy −/− 554.0±14.5 g/24 weeks) (p<0.01). Both female and male 14-week-old chow-fed Pyy −/− mice had a significant increase in total body lean mass (Fig. 3d,f) with the females also showing a significant decrease in whole body fat mass at 14 weeks as determined by DXA (Fig. 2e) . However, female Pyy −/− mice exhibited a marked increase in bodyweight gain from 15 to 28 weeks (Fig. 3a) mice showed a significant 50% increase in fat mass at 28 weeks of age as determined by DXA (Fig. 3e) . This was also confirmed by marked and significant increases in the weight of all white adipose tissue depots measured in female chow-fed Pyy −/− mice at 28 weeks of age (Table 1 ).
These findings show that female but not male Pyy −/− mice develop late-onset obesity, as indicated by significant increases in bodyweight and fat mass when fed a chow diet. It is well documented that long-term exposure to high-fat diet causes obesity in a number of species [27] . Moreover, PYY release from the gut is strongly stimulated by dietary fat [7] . Considering male knock-outs did not develop lateonset obesity, we were interested in determining whether high-fat feeding would induce obesity similarly to that observed in female knock-outs. Therefore we investigated the effect of a high-fat diet on bodyweight and energy homeostasis in male Pyy −/− and wild-type mice. When fed a high-fat diet from 4 weeks of age onwards, male Pyy −/− mice showed no significant change in bodyweight when compared with wild-type mice (Fig. 3c) . However, these high-fat-fed Pyy −/− mice showed a significant increase in total body fat mass when compared with wild-types, as determined by DXA (Fig. 3g) , as well as a significant increase in the weight of the gonadal white adipose tissue depot ( Table 2) .
In young chow-fed female mice, the observed changes in body composition (increased lean mass and decreased fat mass) were associated with a significant decrease in nonfasted food and water intake (Table 1) . Interestingly, however, the increases in bodyweight and/or fat mass observed in older female and high-fat-fed male Pyy −/− mice were not associated with any significant changes in nonfasted food or water intake (Tables 1 and 2 ). Additionally, there was no significant difference between 14-week-old chow-or fat-fed Pyy −/− and wild-type mice with respect to food intake at 1, 2, 8, 24, 48 or 72 h after a 24-h fast (data not shown).
Effect of Pyy deficiency on glucose homeostasis
There was no significant difference between wild-type and Pyy −/− mice with respect to fed serum glucose levels (data not shown). When animals were fasted for 24 h prior to the glucose tolerance test at 13 weeks of age, there was no significant difference between wild-type and knock-out mice with regards to basal serum glucose levels, independently of dietary condition (Fig. 4a-c) . There was no effect of Pyy knock-out on glucose tolerance in female or male chow-fed mice at 13 weeks of age (Fig. 4a,d and b,e) . Interestingly, both male and female chow-fed Pyy −/− mice showed significantly higher serum insulin levels than controls throughout the course of the glucose tolerance tests (Fig. 4g ,j and h, k). As weight gain is known to drive insulin resistance, insulin levels during the glucose tolerance test and the insulin AUC were calculated by normalising for bodyweight. This adjustment of the data did not change the shape of the curves shown in Fig. 4g,h (data not shown) Under conditions of high-fat feeding, male knock-outs were less glucose-tolerant than wild-type mice (p<0.05), shown by a significant increase in the AUC (Fig. 4c,f) . However, this difference did not persist when the data were normalised for bodyweight (wild-type 54.5±2.2 mmol·l
; Pyy −/− 57.4±1.8 mmol·l
) (p= 0.33) Fasting and glucose-induced serum insulin levels are significantly elevated in Pyy knock-outs compared with wild-type mice fed a high-fat diet, whether expressed as absolute values (Fig. 4i,l) ) (p<0.02).
Effect of Pyy knock-out on serum hormone concentrations
Since Pyy deletion significantly increases lean mass in young, chow-fed animals (Fig. 3d,f) , we investigated serum concentrations of IGF-I, the main mediator of the growth effects of growth hormone. No changes were observed in IGF-I levels in the female knock-outs (Table 1) . However, serum IGF-I levels were significantly increased in male Pyy −/− mice under chow-fed but not highfat-fed conditions (Tables 1 and 2) , consistent with the pattern of change in total body lean mass (Fig. 3f) . Testosterone has been shown not only to increase lean mass, but also to decrease fat mass [28] . The serum concentrations of testosterone were increased in male
Pyy
−/− mice, under both chow-fed and fat-fed conditions, and the difference attained statistical significance in the chow-fed animals (Tables 1 and 2 ). There was no T4 (pmol/l) 16.18±1.32 (7) 16.21±1.43 (12) NEFA (mmol/l) 1.64±0.11 (7) 1.30±0.11 (9) Triglycerides (mmol/l) 1.56±0.18 (8) 1.44±0.14 (9) Data are means±SEM (number of mice in parentheses) **p<0.01 vs WT mice (Table 1) , consistent with the observation that our Pyy knock-out strategy did not alter the morphology or the number of glucagon-staining alpha cells in the islets of Langerhans (Fig. 2g,h) .
As an index of hypothalamo-pituitary-thyroid function, an important determinant of resting metabolic rate [29] , serum-free T4 levels, were measured in Pyy −/− and wildtype mice. There was no significant effect of Pyy ablation on serum-free T4 levels in mice of either gender or dietary condition (Tables 1 and 2 Fourteen-week-old female Pyy knock-outs did not show any significant changes in Npy mRNA expression in the arcuate nucleus of the hypothalamus, but exhibited a 51% increase in Pomc mRNA expression compared with controls ( Fig. 6a-d) , which was consistent with the significant reduction in food intake (Table 1 ) and fat mass (Fig. 3e ) observed in these animals. Fourteen-weekold male Pyy −/− mice showed a significant 21% reduction in Npy and a significant 25% increase in Pomc mRNA expression levels in the arcuate nucleus compared with wild-type mice (Fig. 6e-h ). While these changes in male mice were associated with increased lean mass and increased serum concentrations of IGF-I and testosterone, consistent with the expected effects of reduced central NPY-ergic expression [30] , they were not associated with reductions in food intake.
The mRNA expression of the growth-promoting neuropeptide, Ghrh, was unaltered in the arcuate nucleus (Fig. 6i,  j) , but showed a significant 32% increase in the ventromedial hypothalamic nucleus of Pyy −/− mice (Fig. 6k,l) , consistent with activation of the somatotrophic axis and the significantly higher serum levels of IGF-I (Table 1 ) and increased lean mass (Fig. 3f) in the chow-fed male Pyy −/− mice.
Discussion
This study demonstrates that PYY-mediated pathways are important for the regulation of body composition, serum insulin levels and glucose homeostasis. Deficiency of Pyy resulted in late-onset obesity-indicated by significant increases in bodyweight and fat mass-in female mice on a chow diet. Male Pyy −/− mice were resistant to late-onset obesity on a chow diet, but became significantly fatter than wild-types when fed a high-fat diet. These effects of Pyy ablation were associated with significant increases in basal and/or glucose-induced serum insulin levels in both male and female Pyy −/− mice, in the absence of increases in basal or fasting-induced food intake. Moreover, these increases in serum insulin levels were clearly apparent in chow-fed Pyy −/− mice at 13 weeks of age. Since hyperinsulinaemia is causally linked to the aetiology of obese states [23, 24] , it is possible that hyperinsulinaemia contributes to the development of increased adiposity in Pyy −/− mice. The elevated basal and glucose-induced serum insulin levels seen in our Pyy −/− mice are most probably due to the lack of direct PYY inhibitory action on Y1 receptors in the pancreas [31, 32] , as well as indirectly via a lack of PYY stimulation of Y2 receptors in the brainstem, which is known to alter vagal output [33] . PYY and its processed form, PYY3-36, are known to activate Y-receptors in the arcuate nucleus of the hypothalamus and brainstem, thereby regulating the expression of NPY and POMC. Selective activation of Y2 receptors by PYY3-36 administration has been shown to downregulate NPY mRNA and upregulate POMC mRNA expression in the arcuate nucleus [12] . Interestingly, removal of the PYY gene and therefore removal of the ability to activate Y1, Y2 or Y5 receptors either decreased or had no effect on the mRNA expression of NPY in the arcuate nucleus. Moreover, in both male and female mice, Pyy ablation resulted in a significant increase of Pomc expression in the hypothalamic arcuate nucleus. These changes in hypothalamic peptide expression may be caused by the high serum insulin levels observed in Pyy −/− mice, since peripheral insulin administration is known to inhibit hypothalamic Npy and stimulate Pomc mRNA expression [34] . The observed changes in hypothalamic Pomc expression are in keeping with the significant reduction in food intake observed in the young (but not old) female mice. In male Pyy −/− mice, the increase in lean mass and resistance to late-onset obesity on a chow diet may be further attributed to stimulation of the hypothalamo-pituitary somatotrophic axis via increased Ghrh mRNA expression in the ventromedial hypothalamic nucleus and elevated IGF-I levels, as well as the increased serum testosterone levels [28, 35] .
Recently, another report of a Pyy knock-out mouse was published [36] . In that publication, fasting-induced food intake and bodyweight of male and female chow-fed Pyy knock-out animals was no different from that of wild-types, albeit basal food intake, body composition, glucoseinduced glycaemia and insulinaemia, and ageing-and diet-induced obesity were not investigated. It is important to differentiate that PPY expression was also absent in the previously published Pyy −/− mouse model effectively making it a double Pyy/Ppy knock-out mouse.
In summary, we describe that the absence of PYY has a significant effect on body composition and on basal and glucose-induced serum insulin levels. Since circulating PYY levels are decreased in obese, hyperinsulinaemic people [37] , our findings suggest that low circulating PYY concentrations may causally contribute to the development of hyperinsulinaemia and obesity, during ageing or under conditions of long-term consumption of a high-fat diet, respectively. Fig. 6 Effect of PYY deletion on Npy, Pomc and Ghrh mRNA levels in the hypothalamus of 14-week-old female and male wildtype and Pyy −/− mice. High-power bright-field photomicrographs of dipped sections obtained from wild-type and Pyy −/− mice after in situ hybridisation. Npy (a, b, e, f) in the arcuate hypothalamic nucleus (Arc); Pomc (c, d, g, h); Ghrh in the arcuate (i, j) and ventromedial hypothalamic (VMH) nucleus (k, l). Scale bar=10 μm. **p<0.01, ***p<0.001 vs wild-type mice. Pictures are representative of mRNA expression from five mice per group. 3V, 3rd ventricle
